These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 2822054

  • 1. Comparative in vitro activity of ciprofloxacin against aerobic and anaerobic bacteria from clinical isolates.
    Klietmann W, Focht J, Nösner K.
    Arzneimittelforschung; 1987 Jun; 37(6):661-6. PubMed ID: 2822054
    [Abstract] [Full Text] [Related]

  • 2. Antibacterial effect of imipenem in vitro against important aerobic and anaerobic strains isolated from clinical specimens.
    Klietmann W, Focht J, Nösner K.
    Chemioterapia; 1987 Aug; 6(4):243-50. PubMed ID: 3477332
    [Abstract] [Full Text] [Related]

  • 3. In vitro activity of ertapenem: review of recent studies.
    Wexler HM.
    J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii11-21. PubMed ID: 15150179
    [Abstract] [Full Text] [Related]

  • 4. Comparative "in vitro" activity of ciprofloxacin (Bay o9867) and other antimicrobial agents against urinary bacterial isolates.
    Piccolomini R, Ravagnan G.
    Chemioterapia; 1986 Aug; 5(4):249-56. PubMed ID: 3769047
    [Abstract] [Full Text] [Related]

  • 5. CEM-101, a novel fluoroketolide: antimicrobial activity against a diverse collection of Gram-positive and Gram-negative bacteria.
    Putnam SD, Castanheira M, Moet GJ, Farrell DJ, Jones RN.
    Diagn Microbiol Infect Dis; 2010 Apr; 66(4):393-401. PubMed ID: 20022192
    [Abstract] [Full Text] [Related]

  • 6. [The study of drug resistance in aerobic and anaerobic bacterial flora to selected antibacterial drugs].
    Michalska W, Chylak J, Pietkiewicz K.
    Med Dosw Mikrobiol; 1996 Apr; 48(1-2):61-70. PubMed ID: 8926770
    [Abstract] [Full Text] [Related]

  • 7. Doripenem (S-4661), a novel carbapenem: comparative activity against contemporary pathogens including bactericidal action and preliminary in vitro methods evaluations.
    Jones RN, Huynh HK, Biedenbach DJ, Fritsche TR, Sader HS.
    J Antimicrob Chemother; 2004 Jul; 54(1):144-54. PubMed ID: 15190031
    [Abstract] [Full Text] [Related]

  • 8. Tigecycline activity tested against 26,474 bloodstream infection isolates: a collection from 6 continents.
    Sader HS, Jones RN, Stilwell MG, Dowzicky MJ, Fritsche TR.
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):181-6. PubMed ID: 16105562
    [Abstract] [Full Text] [Related]

  • 9. Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit.
    Sader HS, Jones RN, Dowzicky MJ, Fritsche TR.
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):203-8. PubMed ID: 16105565
    [Abstract] [Full Text] [Related]

  • 10. Potency and spectrum of garenoxacin tested against an international collection of skin and soft tissue infection pathogens: report from the SENTRY antimicrobial surveillance program (1999-2004).
    Fritsche TR, Sader HS, Jones RN.
    Diagn Microbiol Infect Dis; 2007 May; 58(1):19-26. PubMed ID: 17383139
    [Abstract] [Full Text] [Related]

  • 11. Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia.
    Fritsche TR, Sader HS, Stilwell MG, Dowzicky MJ, Jones RN.
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):187-93. PubMed ID: 16105563
    [Abstract] [Full Text] [Related]

  • 12. Comparative antimicrobial activity of lomefloxacin, norfloxacin, ofloxacin, ciprofloxacin and enoxacin against > 500 bacterial isolates.
    Ismaeel NA, Tayeb OS.
    Microbios; 1993 Jul; 74(300):147-54. PubMed ID: 8396196
    [Abstract] [Full Text] [Related]

  • 13. Antimicrobial susceptibility of anaerobic and aerobic bacteria isolated from patients with mixed infections in Nicaragua.
    Cáceres M, Carrera E, Palma A, Berrios G, Weintraub A, Nord CE.
    Rev Esp Quimioter; 1999 Dec; 12(4):332-9. PubMed ID: 10855012
    [Abstract] [Full Text] [Related]

  • 14. The sensitivity of gram-negative and gram-positive bacteria to ofloxacin.
    Speciale A, Stefani S, Caccamo F, Nicolosi VM, Nicoletti G.
    Chemioterapia; 1987 Feb; 6(1):17-22. PubMed ID: 3470153
    [Abstract] [Full Text] [Related]

  • 15. [Susceptibility of bacteria isolated from clinical material to ciprofloxacin].
    Namysł E, Galiński J, Szponar M, Piechowicz L.
    Med Dosw Mikrobiol; 1995 Feb; 47(1-2):5-9. PubMed ID: 8523970
    [Abstract] [Full Text] [Related]

  • 16. [In vitro activity of seven gyrase inhibitors of a group of heterocyclic carbonic acids against nonfermenting gram negative rods (nonfermenters)].
    Grimm H.
    Arzneimittelforschung; 1985 Feb; 35(3):570-2. PubMed ID: 2986655
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of the in vitro activity of 9 antimicrobials against bacterial strains isolated from patients in intensive care units in brazil: MYSTIC Antimicrobial Surveillance Program.
    Mendes C, Hsiung A, Kiffer C, Oplustil C, Sinto S, Mimica I, Zoccoli C, Mystic Study Group.
    Braz J Infect Dis; 2000 Oct; 4(5):236-44. PubMed ID: 11063555
    [Abstract] [Full Text] [Related]

  • 18. Antibacterial activity of norfloxacin against 1700 relatively resistant clinical isolates.
    Qadri SM, Lee G, Brodie L.
    Drugs Exp Clin Res; 1989 Oct; 15(8):349-53. PubMed ID: 2598776
    [Abstract] [Full Text] [Related]

  • 19. Potency and spectrum trends for cefepime tested against 65746 clinical bacterial isolates collected in North American medical centers: results from the SENTRY Antimicrobial Surveillance Program (1998-2003).
    Sader HS, Fritsche TR, Jones RN.
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):265-73. PubMed ID: 16105569
    [Abstract] [Full Text] [Related]

  • 20. Comparative in vitro antimicrobial activity of a novel quinolone, garenoxacin, against aerobic and anaerobic microbial isolates recovered from general, vascular, cardiothoracic and otolaryngologic surgical patients.
    Edmiston CE, Krepel CJ, Kehl KS, Seabrook GR, Somberg LB, Almassi GH, Smith TL, Loehrl TA, Brown KR, Lewis BD, Towne JB.
    J Antimicrob Chemother; 2005 Nov; 56(5):872-8. PubMed ID: 16186167
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.